Ngô V M, Laverrière J N, Gourdji D
Groupe de Biologie de la Cellule Neuroendocrine, CNRS URA 1115, Collège de France, Paris.
Mol Cell Endocrinol. 1995 Feb 27;108(1-2):95-105. doi: 10.1016/0303-7207(94)03462-3.
In the present report, we have investigated the role of DNA methylation on the binding and trans-acting properties of transcription factors involved in the regulation of the rat prolactin (rPRL) gene, specifically Pit-1. To this aim we took advantage of a model system composed of three GH3 rat pituitary tumor cell lines that greatly differed in the extent of rPRL gene methylation and in the level of rPRL gene expression. Northern blot analyses indicated that identical species of Pit-1 mRNA were present to similar extent in the three GH3 cell lines. Electrophoretic mobility shift assays further demonstrated that Pit-1 was present in nuclear extracts and displayed equal affinities to bind the 1P responsive element encompassing the -65 to -38 region of the rPRL promoter, whatever the GH3 cell line tested. These data suggested that differential expression of the rPRL gene among cell lines did not result from variable amounts of Pit-1. By combining in vitro methylation and transient transfection experiments with a rPRL promoter-driven CAT construct, we showed that extensive methylation at CpG sites abolished the expression of the reporter gene. Furthermore, in vivo competition assays demonstrated that CpG methylation inhibited gene expression by preventing the binding of transcription factors We propose that related mechanisms linked to DNA methylation might alter the activity of the endogenous PRL gene in the low expressing cell line.
在本报告中,我们研究了DNA甲基化对参与大鼠催乳素(rPRL)基因调控的转录因子(特别是Pit-1)的结合和反式作用特性的影响。为此,我们利用了一个由三种GH3大鼠垂体肿瘤细胞系组成的模型系统,这些细胞系在rPRL基因甲基化程度和rPRL基因表达水平上有很大差异。Northern印迹分析表明,三种GH3细胞系中Pit-1 mRNA的相同种类以相似程度存在。电泳迁移率变动分析进一步证明,无论测试的是哪种GH3细胞系,Pit-1都存在于核提取物中,并且对结合包含rPRL启动子-65至-38区域的1P反应元件具有相同的亲和力。这些数据表明,细胞系间rPRL基因的差异表达并非源于Pit-1含量的不同。通过将体外甲基化和瞬时转染实验与rPRL启动子驱动的CAT构建体相结合,我们发现CpG位点的广泛甲基化消除了报告基因的表达。此外,体内竞争实验表明,CpG甲基化通过阻止转录因子的结合来抑制基因表达。我们提出,与DNA甲基化相关的相关机制可能会改变低表达细胞系中内源性PRL基因的活性。